Clinical events (validated and adjudicated) |
Coronary heart disease: myocardial infarction, coronary insufficiency, angina, coronary heart disease death, sudden coronary disease death, coronary artery bypass surgery, percutaneous transluminal coronary angiography
Heart failure
Stroke, transient ischaemic attack
Peripheral arterial disease: intermittent claudication, lower extremity revascularization
Atrial fibrillation, electrophysiology procedures
Dementia (Alzheimer’s disease, vascular)
Mild cognitive impairment
Cancer
|
Subclinical disease (most measures repeated) |
Ultrasound carotid intima-media thickness and carotid stenosis
Brachial reactivity/endothelial function
Tonometry: arterial stiffness and peripheral arterial tonometry
Echocardiographic structure and function (e.g. left ventricular mass)
CT: coronary artery calcium, abdominal aortic calcium, mitral and aortic valve calcium
Cardiac MRI: cardiac structure, cardiac index, aortic arch plaque
Ankle-brachial index
Walk test: low-level exercise test
Brain MRI: including grey, white, lobar/deep volumes, infarcts, microbleeds, white-matter hyperintensities, fractional anisotropy, regional brain volumes
|
Pulmonary disease and sleep traits (pulmonary function test data available on multiple examinations) |
|
Traditional risk factors (directly measured) |
Systolic and diastolic blood pressure
Fasting blood glucose, haemoglobin A1c, fasting insulin
Fasting lipids
|
Anthropometry (directly measured) |
Height, weight, body mass index
Waist, hip, thigh, neck circumference
CT measures of regional adipose tissue depots: subcutaneous adipose tissue, visceral adipose tissue, pericardial fat, perithoracic fat
Body percent fat (dual-energy X-ray absorptiometry)
|
Lifestyle |
Diet: Willet food frequency questionnaire (calories, supplements)
Smoking
Exercise (self-report, objective measurement with accelerometry)
Alcohol intake
|
Measures of function |
Physical function and mobility
Performance: hand grip, walking speed
Cognitive function (global and multiple domains)
Depression (Center for Epidemiologic Studies Depression Scale)
Social network
|
Medications |
|
Medicare data |
Centers for Medicareand Medicaid Services data since 1991 including International Classification of Diseases codes, charges, medications, procedures on individuals aged ≥ 65 years enrolled in fee for service
|
Bone health |
Fractures, osteoporosis
Osteoarthritis
|
Circulating and urine biomarkers |
Renal function |
|
Inflammatory marker panel |
Acute phase reactants: C-reactive protein
Cytokines: interleukin-6, tumour necrosis factor-α, tumour necrosis factor receptor 2, osteoprotegerin
Selectins: P-selectin, CD40 ligand
Cell adhesion: intercellular adhesion molecule
Chemokines: monocyte chemoattractant protein-1
Oxidative stress: myeloperoxidase, isoprostanes
Lipoprotein-associated phospholipase A2 mass and activity
|
Markers of haemostasis, thrombosis |
Fibrinogen, factor VIIIc, von Willebrand factor, D-dimer, plasminogen activator inhibitor-1, platelet reactivity |
Markers of myocardial injury |
Troponin I, growth differentiation factor-15, ST-2, brain natriuretic peptide, N-terminal atrial natriuretic peptide |
Adipokines |
Leptin, leptin receptor
α-fetuin, resistin, ghrelin
Retinol binding protein-4
Fatty acid binding protein-4
Adiponectin
|
Growth factors |
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, vascular endothelial growth factor angiopoietin-2, brain-derived neurotrophic factor, nerve growth factor
|
Molecules interacting with vessel wall and platelets |
Matrix remodelling markers: matrix metalloproteinase-9, matrix metalloproteinase-3, tissue inhibitor of matrix metalloproteinase-1, N-terminal propeptide of type III procollagen
Plasma homocysteine, asymmetric dimethylarginine
|
Markers of brain injury |
|
Lipid subfractions |
Lipoprotein(a), apoliproteins A1, B48, B100, CI, CII, E, H, J
|
Hormones and vitamins |
Renin-angiotensin-aldosterone pathway
Thyroid function (e.g. thyroid-stimulating hormone)
Sex steroid hormones
Vitamin D, folate, B12, B6, Vitamin E
|